Refine by
Diagnostic Test Kit Articles & Analysis: Older
18 news found
Meanwhile, Creative Diagnostics' research team can optimize existing kits by testing novel antibodies or reagents according to customers' special requirements. ...
Creative Enzymes, a worldwide leading company in diagnostic enzymes manufacturing and supply, is committed to providing customers with diverse enzyme products and custom enzyme-related services for medical and research diagnosis. Recently, Creative Enzymes launched the raw materials for manufacturing Diagnostic Kits. The raw materials provided by Creative Enzymes include enzymes for cholesterol ...
From rapid treatment and combating antimicrobial resistance, to providing personalized medicine, the need for clinical diagnostics, especially in vitro diagnostics, continues to expand. The development of new diagnostics generates value not only in the diagnostic tests themselves, but also in downstream care ...
Revenue growth was driven by a combination of the sale and leasing of our capital equipment to hospitals and orders for our single-use blood volume diagnostics kits for heart failure management, critical care use, as well as other indications. ...
This up to $4M over three-year award will be used to help ImCare Biotech pursue commercialization activities and support a pivotal clinical study for FDA clearance of Seravue®, a diagnostic testing product for Hepatocellular Carcinoma (HCC). This follows the promising results of a phase II clinical study, which demonstrated the high sensitivity and ...
A $7.5 million commitment for the 2021-2022 school year will once again provide diagnostic instruments, test kits and related supplies. "A year after we launched The Just Project, COVID-19 cases are increasing again, and testing is critical to ensuring campus safety," said Fred Lowery, senior vice president and president for ...
“We look forward to ramping Sherlock Biosciences’ CRISPR technology in India at a scale of one million tests per month to contain the crisis created by this pandemic.” The SHERLOCK diagnostic platform can achieve single molecule detection of nucleic acid targets; its name stands for Specific High Sensitivity Enzymatic Reporter unLOCKing. ...
The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic while promoting diverse representation in STEM, today announced that it has granted Cooper International and United PPE licenses to develop and manufacture COVID-19 diagnostic tests using Sherlock’s CRISPR technology. The agreements will ...
The AI software was successfully clinically tested by a US medical institute. Currently, the solution could be used in labs with trained operators, and the testing is done using nasopharyngeal swabs tests. However, the company intends to offer this solution for any point-of-care or even for at-home testing. Eli Assoolin, CEO of ...
"Understanding that the flu season would overlap with surges in COVID-19 infections, Thermo Fisher worked rapidly to develop a new multiplex real-time PCR diagnostic kit for detecting and differentiating SARS-CoV-2, influenza A and influenza B. ...
Using the new kit, laboratories can now can run a single test for SARS-CoV-2, influenza (flu) A/B, and RSV to detect and differentiate between diseases that share similar clinical symptoms, and get the information needed to help diagnose and monitor the spread of these respiratory illnesses in approximately three hours. “We knew that this season’s ...
Through an initiative called "The Just Project," named after pioneering biologist Ernest Everett Just, Thermo Fisher plans to donate $15 million in diagnostic instruments, test kits and related supplies. The company will also provide technical assistance to HBCUs seeking to establish or expand their laboratories to provide regular on-campus ...
Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice, today announced a strategic partnership focused on commercializing next-generation sequencing (NGS)–based diagnostics in Russia. The agreement enables First Genetics ...
Neogen announced today the launch of K-Gold® Plus, a new PNPP (p-nitrophenyl phosphate) substrate that combines the ease of use of its previous PNPP substrate with an improved signal-to-background performance. Similar to the original formulation, Neogen’s new K-Gold Plus is a one-bottle, ready-to-use solution that offers long-term stability and non-hazardous labeling. K-Gold Plus also ...
ImCare Biotech has been awarded Phase II grant by NCI (NIH) for its project on development of a diagnostic kit for early detection of liver cancer. ...
There is a huge gap between the state of the art of health care, which is available in urban areas and developed countries, and the kind of healthcare services available to the rural population in developing countries. Many people in poorer societies suffer because of unavailability of simple and standard medical facilities and diagnostics. Neurosynaptic Communications plans to bridge this gap ...
Vybion has received a $1.3M subcontract on at $7.1M NIH Cooperative Agreement to develop diagnostics for Lassa Virus, a deadly hemorrhagic virus endemic in West Africa. Researchers at Tulane University, in collaboration with Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, have received a ...
ByVybion
Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, has announced an expansion of the collaborative effort for developing test kits for viral hemorrhagic fever (VHF) detection... ...
ByVybion